United States · FDA National Drug Code directory
Dapagliflozin
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 70771-1714_e0ce1921-cd6e-4663-acd0-ae34bd8222fa
- Product NDC
- 70771-1714
- Form
- TABLET
- Composition / generic term
- Dapagliflozin
- Labeler
- Zydus Lifesciences Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20260406
- Source listing expiry
- 20271231
Source-listed ingredients
- DAPAGLIFLOZIN — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (70771-1714-3) · 70771-1714-3
- 90 TABLET in 1 BOTTLE (70771-1714-9) · 70771-1714-9
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →